Show results for
Refine by
Surgeon Console Controls Articles & Analysis
28 news found
JUNE Medical is delighted to announce a new agreement with a major US hospital group to supply the award-winning Galaxy II® self-retaining surgical retractors to over 1,600 hospitals in the US, commencing April 15, 2023. This game-changing device radically improves the safety and ease of surgical retraction for both patients and medical staff; its ergonomic design transforms the way in which ...
Checkpoint Surgical announced today the launch of the Checkpoint Edge™ Nerve Cutting Kit, extending the breadth of the company’s intraoperative nerve care portfolio. The Checkpoint Edge Nerve Cutting Kit is the first offering in Checkpoint Surgical’s planned portfolio of nerve-specific instruments, with further expansion planned in the coming months. “Checkpoint Edge ...
Gières (Grenoble), France, June 17, 2021 - eCential Robotics, a French growth company that designs, manufactures and markets the first unified 2D/3D robotic imaging and surgical navigation system for bone surgery indications, unveiled its surgical robotic arm as a world premiere at the annual meeting of the French Society of Spinal Surgery (SFCR), which is being held from June 17 to ...
Augmedics, a pioneer in augmented reality surgical image guidance, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the U.S. launch of its groundbreaking xvision Spine system (XVS), the first AR guidance system to be used in surgery. xvision Spine allows surgeons to visualize the 3D spinal anatomy of a patient during surgery as if they had “x-ray vision,” and ...
Distalmotion, Revival Healthcare Capital and 415 CAPITAL announce the closing of a USD 90 million Series E financing round to accelerate the adoption of Distalmotion’s surgical robot Dexter. The investment follows Dexter’s successful initial clinical use and supports Distalmotion’s international commercial scaling. More than capital: A partnership of medtech pioneers and ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2021 year-end corporate update. Fourth Quarter Highlights Over 500 procedures were performed globally during the quarter, representing growth of over 25% over the ...
Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the 40th Annual J.P. Morgan Healthcare Conference. The Company’s virtual presentation will take place on Thursday, January 13, 2022 at 9:00 am Eastern Time. In addition, ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Private Healthcare Institution Railway Clinical Hospital RZD Medicine of Rostov-on-Don (“RZD Medicine”), located in Rostov, Russia, has initiated its Senhance® Robotic ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Franklin Medical Center in Winnsboro, Louisiana has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are excited to bring the Senhance ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2021. Recent Highlights Record quarter for procedures performed using Senhance® Surgical Systems, growing 47% over the ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Shinmatsudo Central General Hospital in Matsudo, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are excited to partner with ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 third quarter financial and operating results after the market closes on Wednesday, November 3, 2021. The Company will host a conference call to discuss ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Hirosaki University Hospital has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are excited to add a system at Hirosaki University Hospital ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Paul LaViolette, who has served as the Company’s Board Chair since 2013, will step down as Chair in late October, and intends to leave the Board before the end of the year. ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Sapporo Medical University Hospital, located in Hokkaido, Japan, has entered into an agreement to lease and utilize a Senhance® Surgical System. “The Department of Surgery, ...
Redwood City, CA, September 16, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today the Food and Drug Administration (FDA) has given clearance of the Sonata® System 2.2 which provides important new benefits for facilities, physicians and patients. These benefits include: ...
New View Surgical, Inc., a medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration for its VisionPort™ System. The VisionPort™ imaging and access system simplifies laparoscopic procedures for hospitals and provides surgeon-controlled ...
ExsoMed Corporation, a privately held U.S.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, today announced that it will make commercially available an enhanced version of its ArcPhix angled compression screw to promote a controlled approach to achieving functional flexion in DIP (distal interphalangeal) joint fusions. The ArcPhix angled ...
Augmedics, a pioneer in augmented reality surgical image guidance, announced today that it has raised $36 million in an over-subscribed Series C financing with an international syndicate of Israel-US investors. This comes only eight months after the company closed a $21 million Series B financing, bringing the total funding to date to $63 million. H.I.G. Capital, Revival Healthcare Capital, and ...
Ivantis Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device intended to lower eye pressure for open-angle glaucoma patients, announced today that the American Academy of Ophthalmology (AAO) has designated the Hydrus Microstent as “Level 1, Moderate Quality, Strong Recommendation” — the highest designation of any MIGS device ...